Test 3 (Chapters 7, 9, 12) Flashcards
(173 cards)
What part of nervous system do sedatives and hypnotics effect
Central nervous system (CNS) depressants are a diverse group of drugs that slow physical and mental activities, relieve anxiety, diminish awareness, and increase sleep. Sedatives and hypnotics are two types of CNS-depressant drugs.
What are sedatives and hypnotics and that are two popular classes
Sedatives are drugs that relieve anxiety, cause relaxation, and produce mild depression of the CNS. Hypnotics induce drowsiness and sleep (hypnos=Greek word for “sleep”). Two popular classes of sedative/hypnotics are barbiturates and benzodiazepines. Barbiturates are used mainly for an anesthesia and treatment of seizure disorders, while benzodiazepines (BZDs) are used mainly as muscle relaxants and to reduce anxiety.
What is valerian used for
Valerian root has been used for thousands of years as a remedy for insomnia.
First synthetic drug truly classified as hypnotic
Synthesized in 1832, chloral hydrate quickly induces a long, deep sleep. Today it is sometimes given to infants as a sedative prior to surgical or EEG procedures or to help people withdraw from opioid or alcohol addiction.
That schedules are sedatives and hypnotics in
• barbiturates: Schedule IV
• BZD: Schedule IV
• Quaalude: Schedule III
• GHB: Schedule I
Who synthesized barbiturates and how
In 1864, Adolf von Baeyer, a German scientist, synthesized barbituric acid by combining malonic acid from apples with urea, a waste product found in urine.
Most frequently prescribed benzodiazepines and what they were originally marketed for
The most frequently prescribed benzodiazepines in Canada include Valium (diazepam), Ativan (lorazepam), and Xanax (alprazolam), totalling over 26 million prescriptions in Canada in 2017. During their early days, benzodiazepines were predominantly marketed to women to help them deal with the stress of daily life.
How safe are benzodiazepines
At first, benzodiazepines were viewed as extremely safe and free from the problems of tolerance, dependence, and withdrawal. BZDs are relatively safe when used for short periods (and are much safer than barbiturates), but long-term use can cause tolerance, dependence, and withdrawal problems.
Prevalence of Sedative and Hypnotic Use
In 2017 CTADS reported that 11.7 per cent of the population used sedatives. Sedative/hypnotic use is higher in females (14.3 per cent) than males (9.1 per cent), and increases with age: about 5.1 per cent of 15–19-year-olds, 7.5 per cent of 20–24-year-olds, and 12.6 per cent of those age 25 and older report past-year use.
Different categories of barbiturates and what they are used for
Barbiturates are categorized as long-acting, intermediate-acting, short-acting, or ultra-short-acting, based on their duration and this decides their clinical use. Shorter-acting drugs are more lipid-soluble and take effect rapidly, because they quickly enter the bloodstream and easily cross the BBB and are cleared from system faster. These short-acting barbiturates are more likely to be abused.
Longer-acting drugs are best used as anticonvulsants in treatment of epilepsy or to reduce anxiety. Intermediate- and shorter-acting drugs are used to treat insomnia, for emergency management of seizures, and as a preanaesthetic sedative. Ultra-short-acting barbiturates can be used to rapidly anaesthetize a patient in emergency situations and to bring them out of anaesthesia quickly as well and they leave the patient with no memory of the experience.
What are drugs that reduce anxiety called
Anxiolytics
Routes of Administration of sedatives
Sedatives can be administered rectally or by injection, but they are most commonly administered orally. Some anaesthetic medications or drugs given to treat emergency seizures or status epilepticus (epileptic seizures following one another in which the sufferer remains unconscious) are administered intravenously.
Sedative and hypnotic absorption + difference between BZD absorption and barbiturate
Sedative/hypnotics are absorbed into the bloodstream after oral administration. Barbiturates are absorbed in the stomach, while benzodiazepines are absorbed in the small intestine; this means that BZDs are absorbed into the bloodstream more slowly than are barbiturates.
Distribution of sedatives in bloodstream is determined by what
Once in the blood, a sedative’s distribution is determined by its lipid solubility. Barbiturates are more fat-soluble than BZDs; as a result, barbiturates are better able to cross the blood brain barrier, leading to a faster onset of action. Shorter-acting barbiturates are especially lipid-soluble.
Barbiturates and fatty tissues in body
Barbiturates stored in fatty tissues of the body. From these body fat deposits, the barbiturate is released slowly into the blood. The amount of body fat a person has can influence their response to barbiturates and BZDs. Although the initial effects of a short-acting barbiturate may recede quickly, the drug may be released from body fat deposits and then circulate at low levels in the blood for a significant period of time.
How are sedatives metabolized + what happens when they enter bloodstream
Barbiturates and benzodiazepines are metabolized in the liver. When these drugs enter the bloodstream, some bind to plasma proteins. Only unbound molecules of the drug are free to bind to receptor sites and exert an action. As the unbound molecules of barbiturates are metabolized and excreted, the drug that was previously stored in fat or that was bound to plasma proteins becomes free and available for metabolism. The balance between the free and bound forms of the drug is responsible for the varying durations of action for different barbiturates.
Benzodiazepines undergo two major pathways of metabolism:
Oxidation= such as diazepam (Valium), chlordiazepoxide (Librium), and flurazepam (Dalmane), produce active metabolites, prolonging their duration of action until they are further detoxified by metabolism and then excreted.
Conjugation= metabolized to pharmacologically inactive, water-soluble products that are excreted in urine.
How does liver diseases/ weakness affect metabolism of sedatives
Metabolism is decreased. Half life becomes much longer, effects last very long
Sedatives Mechanism of Action on receptors
Sedative/hypnotics exert their effects by binding to GABA receptors. Barbiturates and BZDs both work on the receptor, but by slightly different mechanisms.
GABA receptors are _____ (what type)
ionotropic, meaning that the receptor itself is an ion channel
Benzodiazepines Interaction with the GABA-A Receptor
GABA-A receptors in brain (limbic system and cortex) have binding sites for benzodiazepines, When a BZD binds to a GABA receptor, the shape of the receptor changes, increasing the frequency of chloride channel openings and enhancing GABA’s inhibitory effects. The GABA receptors that control respiration and other vegetative processes do not have many BZD sites, so BZDs do not suppress respiration as much as barbiturates do. There are also GABA receptors with BZD binding sites in the peripheral nervous system, which modulate the immune system and are involved in the body’s response to injury.
Benzodiazepines effect on adenosine
BZDs slightly block the reuptake of the inhibitory neurotransmitter adenosine, which acts to increase adenosine’s activity at the synapse and is responsible for some of the anticonvulsant, anxiolytic, and muscle relaxant effects of BZDs.
Barbiturates’ Interaction with the GABA-A Receptor
Unlike benzodiazepines, barbiturates don’t act at a specific single site on the GABA-A receptor, they bind to multiple cavities on the surface of the receptor. Barbiturates have a more general effect that enhances the inhibitory activity of GABA.
Difference between effects of BZDs and barbiturates on chloride channels
Barbiturates increase duration of channel opening, even in the absence of GABA which is a reason why barbiturates are more dangerous than BZDs. BZDs can only open the chloride channel if GABA is present. Because barbiturates have a more general effect on GABA receptors, they have more widespread sedating effects than do the BZDs. Along with widespread CNS depression, barbiturates can suppress cognitive function, muscle activity, and respiration.